CL
ACAD icon

CSS LLC’s Acadia Pharmaceuticals ACAD Stock Holding History

CSS LLC’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,200
Closed -$121K – 1148
2021
Q4 		$121K Sell
5,200
-1,602
-24% -$32.2K ﹤0.01% 984
2021
Q3 		$113K Sell
6,802
-2,673
-28% -$51.5K ﹤0.01% 961
2021
Q2 		$231K Sell
9,475
-9,761
-51% -$220K 0.01% 820
2021
Q1 		$496K Buy
+19,236
New +$847K 0.02% 588

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CSS LLC's ACAD Position: Q1 2022 in Review

CSS LLC sold out of Acadia Pharmaceuticals (ACAD) in Q1 2022, closing a stake of 5,200 shares — an estimated $121K sold.

CSS LLC first reported a position in ACAD in Q1 2021 and held it in 4 quarters. The position peaked at $496K in Q1 2021. 263 funds tracked by Wall St. Rank hold ACAD as of Q1 2022.

  • CSS LLC reported no remaining Acadia Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • CSS LLC sold 5,200 Acadia Pharmaceuticals shares in Q1 2022, an estimated $121K.
  • CSS LLC first reported a position in Acadia Pharmaceuticals in Q1 2021 and held it in 4 quarters.
  • CSS LLC's Acadia Pharmaceuticals position peaked at $496K in Q1 2021.
  • 263 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2022.

Based on CSS LLC's 13F filing for Q1 2022, filed 16 May 2022.